Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Adaptive Biotechnologies Corporation (ADPT) had Return on Tangible Equity of 11.48% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$93.97M |
|
$9.55M |
|
$18.16M |
|
$75.82M |
|
$83.68M |
|
$10.29M |
|
$-0.74M |
|
$9.54M |
|
$9.54M |
|
$9.54M |
|
$9.54M |
|
$9.54M |
|
$9.54M |
|
$10.29M |
|
$14.18M |
|
152.43M |
|
163.16M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
$281.44M |
|
$37.50M |
|
$209.18M |
|
$490.61M |
|
$83.36M |
|
-- |
|
$203.00M |
|
$286.36M |
|
$204.25M |
|
$83.13M |
|
$204.25M |
|
152.58M |
|
| Cash Flow Statement Financials | |
$-48.04M |
|
$46.20M |
|
$8.74M |
|
$50.82M |
|
$57.72M |
|
$6.91M |
|
$38.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.68% |
|
10.95% |
|
10.95% |
|
-- |
|
10.16% |
|
10.16% |
|
$-50.36M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
1.83 |
|
2.10 |
|
42.93 |
|
4.67% |
|
|
Return on Tangible Equity |
11.48% |
1.95% |
|
4.67% |
|
$1.34 |
|
$-0.31 |
|
$-0.29 |
|